Located in Lausanne, Biopôle is one of the largest life sciences campuses in Europe. It boasts state-of-the-art laboratories, office buildings and amenities to serve our community of renowned companies, academic institutions and research organisations. In 2023, more than 130 organisations are present on site. Most of all, we pride ourselves on ideas that cross boundaries, generations and disciplines – and on the spirit of collaboration that flows throughout our whole community. Founded in 2004 by the cantonal authorities of Vaud, Biopôle SA is a private, not-for-profit organisation that owns, manages and promotes the life sciences campus.

State of Vaud, Office for Economic Affairs and Innovation (SPEI) The Office for Economic Affairs and Innovation (SPEI) supports companies that are located in the Canton of Vaud, especially those involved in the sectors of advanced technology and industry. SPEI provides direct financial support to them, also advises and puts them in contact with organizations that are appropriate to their specific needs.

Swiss Post has a long-standing reputation for transporting goods and information confidentially and reliably. For several years, it has also been using this core competency to support the Swiss healthcare sector – as a trustworthy partner in digitization and logistics processes. Swiss Post aims to be the driving force behind the networking of the healthcare sector, ensuring that service providers can cooperate and structure their processes more efficiently and, in turn, can increase the quality of healthcare provision. To this end, it provides “Cuore – the Swiss health platform”. A secure and neutral platform where service providers can access the digital services that are right for them. Wherever it is possible and makes sense to do so, Swiss Post connects its services with the information and goods streams for the healthcare system. As such, it provides reliable solutions for comprehensive provision, ensuring that supply chain management runs smoothly from ordering to delivery and sterile preparation. This combination of the physical and the digital along the entire treatment path enables service providers to concentrate on their medical competencies and, by extension, on caring for their patients – thanks to the range of services provided by Swiss Post.

The CSS Group is a major driver of innovation in digital health solutions. Ten years ago, this health insurance company launched an ambitious innovation strategy. As a result, CSS is now involved in all three main stages of innovation. Together with ETH Zurich and the University of St. Gallen, the CSS Health Lab is conducting research into new digital health technologies focusing on chronic illnesses. The Future of Health Grant supports young start-ups by providing tailor-made coaching and monitoring. Prestigious partners from the health system share their know-how to help them accelerate their growth, leading to the creation of a unique ecosystem for agile innovation. CSS SwissHealth Ventures AG is investing in digital health start-ups seeking to broaden their customer base.

About Ferring Pharmaceuticals Ferring Pharmaceuticals is a research driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately owned Ferring employs over 7,000 people worldwide. The company has operating subsidiaries in more than 50 countries and markets its products in over 100 countries.

With 21 clinics and over 60 ambulatory centers spread through 13 cantons cover the country’s four linguistic regions, Swiss Medical Network is one of the two leading private groups of clinics in Switzerland. It provides a state-of-the-art medical infrastructure and offers patients first-class inpatient and outpatient care in all specialties. It has more than 4’000 employees and works with over 2’250 doctors. The facilities offer a total of 1,450 beds and more than 75,000 surgical procedures are performed there every year. Its growth strategy is based on the acquisition of existing establishments and the restructuring of their operations. Its principal goal consists in offering top-flight medical and hospital care to patients from Switzerland and abroad.

BioAlps is a diversified Life Sciences cluster and represents over 1350 Western Switzerland organisations in the fields of biotech, medtech, pharma, nutrition and e-health. Supported by the 15 academic institutions, the 7 cantons of Western Switzerland and the State Secretariat for Economic Affairs (SECO), BioAlps offers a dynamic network and an innovative and supportive environment with immediate access to the world of Life Sciences. The Association’s aim is to promote the excellence and performance of the industry in the region. The community can network and share business opportunities during events organised and supported by BioAlps in Switzerland and internationally.

CSL (ASX:CSL; USOTC:CSLLY) is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For inspiring stories about the promise of biotechnology, visit CSL.com.

Philip Morris International’s global Research and Development Center is based in Neuchâtel. More than 400 scientists and engineers with expertise in biology, chemistry, physics, electronics, mathematics, computer programing and statistics work on the development and the scientific assessment of novels products which have the potential to be less harmful than cigarettes. While Philip Morris International’s Research & Development Center is modern and has are state-of-the art equipment, the company also works hand in hand with dozens of Swiss small and medium companies which provide a vital know-how on innovation.

What began over 125 years ago in Basel with a visionary idea is today one of the world's leading healthcare companies. With over 14,000 employees, Switzerland is and remains the central location for both Roche divisions, Pharmaceuticals and Diagnostics. Roche Pharma (Switzerland) Ltd is the Swiss national subsidiary of Roche Pharmaceuticals, and its almost 150 employees are committed to ensuring that patients in Switzerland have access to innovative Roche medicines. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology, rare diseases and ophthalmology.

sitem-insel is the Swiss Institute for Translational and Entrepreneurial Medicine. Our mission is to bring innovation to the patients as quickly as possible, and to do so in the highest quality. sitem-insel is located at the Insel-Campus Bern and benefits from its proximity to the largest Swiss university hospital (Inselspital) as well as to the largest medical faculty in Switzerland (University of Bern). In sitem-insel, a wide variety of units from the hospital, industry, research and education are networked under one roof and pursue innovation for the benefit of the patient. The architecture of the 20,000m2 transparent glass building reflects the idea of openness and multidisciplinary collaboration.

Unisanté is an académic center for general medicine and public health, active in many fields : primary care, care for vulnerable populations, occupational medicine, health promotion and prevention, organization of the healthcare system, as well as research and university teaching. Its aim is to maintain and improve the health of the population of Vaud. Unisanté is the only interdisciplinary center in Switzerland to bring together such a wide range of skills in public health and outpatient care under one roof. The institution employs around a thousand people, including some fifty faculty members. Unisanté publishes over 400 articles in scientific journals and carries out some 300,000 patient contacts every year.

At the heart of an urban area of 300'000 residents on the shores of Leman Lake “Health Valley”, the City of Lausanne is the capital of Canton of Vaud, a leading European hub for education, technology and innovation. Lausanne hosts a dense network of internationally renowned institutes such as the Ecole Polytechnique Fédérale de Lausanne (EPFL), the University Hospital of Lausanne (CHUV), the Institute for Management Development (IMD), the University of Lausanne (UNIL) and the Ecole Hôtelière de Lausanne (EHL). This dynamic ecosystem provides excellent opportunities for development and transfers in a number of fields, notably the life sciences, medical care, sports and nutrition. Lausanne is also proud to welcome the headquarters of the International Olympic Committee and to be distinguished as the unique Olympic capital. Lausanne offers visitors and residents an outstanding quality of life, a flexible labor market, a thriving cultural venue, affordable housing and a safe environment in a central location in Europe.

L'Agefi" has been covering economic, financial, and political news Since 1950. It offers a unique flow of specialized French-language information on Switzerland and Swiss companies. A must-read monitoring tool for decision-makers, "L'Agefi" is available online and in a paper or e-paper issue on Wednesdays and Fridays. The editorial offering also includes a series of supplements, including Agefi Immo, Indices and Agefi Life. L'Agefi" is also an agency, with a commercial department offering services to companies to help them develop their business.